A Physicist Offers His Prescription For Improved Science News Coverage

When the "fifth force" burst upon the scientific scene in January of 1986, its arrival was noted with great fanfare by the nation's news media. "Hints of Fifth Force in Universe Challenge Galileo's Findings," proclaimed the New York Times the day after the discovery was announced in the journal Physical Review Letters. (56:3, Jan. 6, 1986). But when the force was pronounced all but dead almost four years later at a December 1989 conference in Les Arcs, France, no reporter was present to note it

Written byClifford Will
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When the "fifth force" burst upon the scientific scene in January of 1986, its arrival was noted with great fanfare by the nation's news media. "Hints of Fifth Force in Universe Challenge Galileo's Findings," proclaimed the New York Times the day after the discovery was announced in the journal Physical Review Letters. (56:3, Jan. 6, 1986). But when the force was pronounced all but dead almost four years later at a December 1989 conference in Les Arcs, France, no reporter was present to note its lonely passing, and you are unlikely to find its obituary in your morning paper. The demise of the fifth force turned out to be as important an advance for physics as was its birth, yet the headlines have failed to materialize.

Understandably, a scientific discovery that challenges conventional wisdom is more newsworthy than the finding that the establishment was right after all, and science reporting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies